Global Cancer Supportive Care Drugs Market to Reach $17.8 Billion by 2035

Cancer supportive care drugs market was valued at $13.8 billion in 2025 and is projected to reach $17.8 billion by 2035, growing at a CAGR of 2.6% during the forecast period (2026-2035). The global cancer supportive care drugs market is experiencing significant growth, driven by the rising prevalence of cancer and the increasing need to manage treatment-related side effects effectively. Supportive care therapies, including granulocyte colony-stimulating factors, erythropoiesis-stimulating agents, antiemetics, bisphosphonates, opioids, and NSAIDs, are playing a crucial role in improving patient outcomes and maintaining adherence to therapy. In 2024, the US recorded over 2 million new cancer cases, averaging approximately 5,480 diagnoses per day, while the UK has nearly 3.5 million individuals living with cancer and more than 420,000 new cases annually.

Browse the full report description of “Cancer Supportive Care Drugs Market Size, Share & Trends Analysis Report by Therapeutic Class (Granulocyte Colony Stimulating Factors, Erythropoiesis Stimulating Agents, Antiemetics, Bisphosphonates, Opioids, NSAIDs, Others), by Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Stomach Cancer and Other Cancers) and by Distribution Channel (Hospital Pharmacies, Retail / Drug Stores, and Online Pharmacies), Forecast (2026-2035)” at https://www.omrglobal.com/industry-reports/cancer-supportive-care-drugs-market

In India, cancers of the oral cavity and lungs in males, and cervix and breast in females, account for more than half of the cancer burden. The growing patient population, coupled with longer survival rates due to advanced therapies, is driving increased adoption of supportive care drugs across hospitals, retail pharmacies, and home care settings. Ongoing innovations in drug formulations and delivery mechanisms, as well as strategic collaborations among global pharmaceutical leaders, are further fueling market expansion. As cancer incidence continues to rise worldwide, the global market for cancer supportive care drugs is poised for sustained growth, reflecting the essential role of these therapies in comprehensive oncology care.

Leading Companies and Patient Support Initiatives

The global cancer supportive care drugs market is dominated by leading pharmaceutical companies such as Amgen Corp., Johnson & Johnson Services Inc., F. Hoffmann?La Roche Ltd., GlaxoSmithKline Plc, and Merck & Co. Inc., among others. These major players are actively expanding their product portfolios, investing in innovative therapies, and implementing patient-centric programs to enhance access and improve treatment outcomes.

• In March 2025, Manulife Hong Kong launched its “Cancer Drug Support Service” in collaboration with Prosper Health and Shenzhen New Frontier United Family Hospital. The service provides eligible customers with access to cost-effective cancer medications in mainland China, assisted by personalized medical case managers and coordinated consultations with hospital specialists. Additional support includes logistical services such as complimentary door-to-door transportation, aiming to reduce financial and administrative burdens for patients undergoing cancer treatment.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-  
• Deliverable
• Technology
• Application
• End User
• Competitive Landscape – Amgen Corp., Johnson & Johnson Services Inc., F. Hoffmann?La Roche Ltd., GlaxoSmithKline Plc, and Merck & Co. Inc.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Cancer Supportive Care Drugs Market Report Segment

By Therapeutic Class

• Granulocyte Colony?Stimulating Factors (G?CSFs)
• Erythropoiesis?Stimulating Agents (ESAs)
• Antiemetics
• Bisphosphonates
• Opioids
• NSAIDs (Non?Steroidal Anti?Inflammatory Drugs)
• Others

By Application

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Liver Cancer
• Stomach Cancer
• Other Cancers (e.g., melanoma, leukemia)

By Application

• Drug Discovery & Development
• Diagnostics
• Agriculture & Animal Research
• Precision Medicine
• Other

By Distribution Channel

• Hospital Pharmacies
• Retail / Drug Stores
• Online Pharmacies

Global Cancer Supportive Care Drugs Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cancer-supportive-care-drugs-market